Market Closed -
Nasdaq
04:00:00 2024-07-12 pm EDT
|
5-day change
|
1st Jan Change
|
2.15
USD
|
+9.14%
|
|
+27.22%
|
+48.28%
|
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- From a short-term investment perspective, the company presents a deteriorated fundamental configuration.
- Analysts expect a sharply increasing business volume for the group, with high growth rates in the coming years.
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- Over the past year, analysts have regularly revised upwards their sales forecast for the company.
- Growth remains a strong point in this company. In their sales forecast, analysts sound optimistic with regard to sales prospects.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- The opinion of analysts covering the stock has improved over the past four months.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
- The group usually releases upbeat results with huge surprise rates.
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- Low profitability weakens the company.
- With an enterprise value anticipated at 3.4 times the sales for the current fiscal year, the company turns out to be overvalued.
- For the last few months, analysts have been revising downwards their earnings forecast.
- The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
|
1st Jan change
|
Capi.
|
Investor Rating
|
ESG Refinitiv
|
---|
| +48.28% | 381M | |
-
| | -2.50% | 1.26B | |
-
| | +61.51% | 897M |
-
|
-
| | -16.69% | 792M | | C | | -45.53% | 337M | |
-
| | +39.63% | 253M |
-
|
-
| | -1.39% | 201M |
-
|
-
| | +26.91% | 128M |
-
|
-
| | +89.86% | 56.83M |
-
|
-
|
4 months Revenue revision
Divergence of analysts' opinions
Divergence of Target Price
|